Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The rise of apoptosis: targeting apoptosis in hematologic malignancies
Rebecca Valentin, Stephanie Grabow, Matthew S. Davids
Blood (2018) Vol. 132, Iss. 12, pp. 1248-1264
Open Access | Times Cited: 137

Showing 1-25 of 137 citing articles:

Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
Lei Zhong, Yueshan Li, Liang Xiong, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1176
The role of BCL-2 family proteins in regulating apoptosis and cancer therapy
Shanna Qian, Wei Zhong, Wanting Yang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 457
AZD4573 Is a Highly Selective CDK9 Inhibitor That Suppresses MCL-1 and Induces Apoptosis in Hematologic Cancer Cells
Justin Cidado, Scott Boiko, Theresa A. Proia, et al.
Clinical Cancer Research (2019) Vol. 26, Iss. 4, pp. 922-934
Open Access | Times Cited: 224
BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy
Prashanthi Ramesh, Jan Paul Medema
APOPTOSIS (2020) Vol. 25, Iss. 5-6, pp. 305-320
Open Access | Times Cited: 102
Single-Cell Transcriptomics Identifies the Adaptation of Scart1+ Vγ6+ T Cells to Skin Residency as Activated Effector Cells
Likai Tan, Inga Sandrock, Ivan Odak, et al.
Cell Reports (2019) Vol. 27, Iss. 12, pp. 3657-3671.e4
Open Access | Times Cited: 99
Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseases
Epiphani C. Simmons, Natalie E. Scholpa, Rick G. Schnellmann
Experimental Neurology (2020) Vol. 329, pp. 113309-113309
Open Access | Times Cited: 87
Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors
Amr K. A. Bass, Mona S. El‐Zoghbi, El-Shimaa M. Nageeb, et al.
European Journal of Medicinal Chemistry (2020) Vol. 209, pp. 112904-112904
Closed Access | Times Cited: 80
Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma
Luciano J. Costa, Faith E. Davies, Gregory Monohan, et al.
Blood Advances (2021) Vol. 5, Iss. 19, pp. 3748-3759
Open Access | Times Cited: 64
Targeting the tumor microenvironment in chronic lymphocytic leukemia
Rebecca Svanberg Teglgaard, Sine Janum, Piers Patten, et al.
Haematologica (2021) Vol. 106, Iss. 9, pp. 2312-2324
Open Access | Times Cited: 62
Advances in small-molecule fluorescent probes for the study of apoptosis
Ya‐Xi Ye, Jian-Cheng Pan, Haichao Wang, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 18, pp. 9133-9189
Closed Access | Times Cited: 16
Natural compounds target programmed cell death (PCD) signaling mechanism to treat ulcerative colitis: a review
Bo Chen, Xinqian Dong, Jinlong Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 13
Superior efficacy of cotreatment with BET protein inhibitor and BCL2 or MCL1 inhibitor against AML blast progenitor cells
Warren Fiskus, Tianyu Cai, Courtney D. DiNardo, et al.
Blood Cancer Journal (2019) Vol. 9, Iss. 2
Open Access | Times Cited: 65
Targeting Mitochondrial Apoptosis to Overcome Treatment Resistance in Cancer
Natalie Ngoi, Clarice Shi Hui Choong, Joanne Lee, et al.
Cancers (2020) Vol. 12, Iss. 3, pp. 574-574
Open Access | Times Cited: 64
Sirt6 promotes tumorigenesis and drug resistance of diffuse large B-cell lymphoma by mediating PI3K/Akt signaling
Juan Yang, Ying Li, Ya Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 58
GSK-3β-mediated activation of NLRP3 inflammasome leads to pyroptosis and apoptosis of rat cardiomyocytes and fibroblasts
Shuhui Wang, Liu-Gen Cui, Xue-Ling Su, et al.
European Journal of Pharmacology (2022) Vol. 920, pp. 174830-174830
Closed Access | Times Cited: 29
The crosstalk among autophagy, apoptosis, and pyroptosis in cardiovascular disease
Lin Cong, Yunpeng Bai, Zhigang Guo
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 29
Combination p53 activation and BCL-xL/BCL-2 inhibition as a therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia
Hayden L. Bell, Helen J. Blair, Samantha J. Jepson Gosling, et al.
Leukemia (2024) Vol. 38, Iss. 6, pp. 1223-1235
Open Access | Times Cited: 7
New Quinoline-Based Heterocycles as Anticancer Agents Targeting Bcl-2
Rania Hamdy, Samia A. Elseginy, Noha I. Ziedan, et al.
Molecules (2019) Vol. 24, Iss. 7, pp. 1274-1274
Open Access | Times Cited: 47
Resistance to the Proteasome Inhibitors: Lessons from Multiple Myeloma and Mantle Cell Lymphoma
María Gonzalez-Santamarta, Grégoire Quinet, Diana Reyes-Garau, et al.
Advances in experimental medicine and biology (2020), pp. 153-174
Open Access | Times Cited: 42
A Targeted Erythrocyte Membrane-Encapsulated Drug-Delivery System with Anti-osteosarcoma and Anti-osteolytic Effects
Xin Wu, Xiaobo Zhang, Wanjiang Feng, et al.
ACS Applied Materials & Interfaces (2021) Vol. 13, Iss. 24, pp. 27920-27933
Closed Access | Times Cited: 37
Potential anti-cancer properties of malvidin and its glycosides: Evidence from in vitro and in vivo studies
Rachit Sood, Sanjay Sanjay, Hyo‐Kyoung Choi, et al.
Journal of Functional Foods (2024) Vol. 116, pp. 106191-106191
Open Access | Times Cited: 5
Leukemia therapy by flavonoids: Future and involved mechanisms
Raedeh Saraei, Faroogh Marofi, Adel Naimi, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 6, pp. 8203-8220
Closed Access | Times Cited: 42
The evolving role of translocation t(11;14) in the biology, prognosis, and management of multiple myeloma
Agne Paner, Pritesh Patel, Binod Dhakal
Blood Reviews (2019) Vol. 41, pp. 100643-100643
Closed Access | Times Cited: 41
IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia
Chunhua Song, Zheng Ge, Yali Ding, et al.
Blood (2020) Vol. 136, Iss. 13, pp. 1520-1534
Open Access | Times Cited: 39
Pediatric Acute Myeloid Leukemia (AML): From Genes to Models Toward Targeted Therapeutic Intervention
Thomas Mercher, Juerg Schwaller
Frontiers in Pediatrics (2019) Vol. 7
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top